Skip to main content
. Author manuscript; available in PMC: 2013 Sep 18.
Published in final edited form as: Hum Immunol. 2010 Mar 10;71(5):451–455. doi: 10.1016/j.humimm.2010.02.013

Table 1. Patient characteristics.

Cumulative incidence of graft loss, death, and death-censored graft loss over 4-year follow-up

Clinical outcome No. of events %
1-Year graft loss 8 10.96
2-Year graft loss 15 20.55
3-Year graft loss 17 23.29
4-Year graft loss 21 28.77
1-Year death 8 10.96
2-Year death 11 15.07
3-Year death 11 15.07
4-Year death 12 16.44
1-Year death-censored graft loss 1 1.37
2-Year death-censored graft loss 5 6.85
3-Year death-censored graft loss 7 9.59
4-Year death-censored graft loss 10 13.7

Serum creatinine and MDRD GFR over 4-year follow-up among the 73 patients

No. of events Creatinine level (mg/dl) (mean ± SD) MDRD GFR (ml/min/1.73 m2) (mean ± SD)

1-Year creatinine 64 1.62 ± 0.80 51.14 ± 17.93
2-Year creatinine 54 1.80 ± 0.90 49.24 ± 22.46
3-Year creatinine 51 1.93 ± 1.47 49.24 ± 21.94
4-Year creatinine 41 1.79 ± 0.95 49.24 ± 21.52

Dipstick proteinuria over 4-year follow-up among the 73 patients

No. of events Proteinuria (g/day) (mean ± SD)

1-Year proteinuria 64 1.04 ± 1.30
2-Year proteinuria 46 1.23 ± 1.45
3-Year proteinuria 38 0.89 ± 1.31
4-Year proteinuria 40 1.15 ± 1.41